Midway Capital Research & Management

Position in MRK — Merck & Co., Inc.

CIK 2115416 CHICAGO, IL

Position in MRK

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$129,656

+$8,284 QoQ

Shares Held

1,009

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#3,562

of 3,769 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Midway Capital Research & Management holds $3,629,650 across 5 Drug Manufacturers - General names. MRK ranks #3 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	8,770	$2,227,316
2	PFE	Pfizer Inc	50,390	$1,213,391
3	MRK	Merck & Co., Inc. This page	1,009	$129,656
4	NVS	Novartis AG	363	$56,889
5	LLY	ELI LILLY & Co	2	$2,398

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$129,656	1,009	0.0%	Shares	Sole	2026-07-14
2026-03-31	$121,372	1,009	—	Shares	Sole	2026-04-13
No filing history on record for this holder in this stock.